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Abstract
The lateral amygdala is a brain structure that plays an important role in regulating fear
and anxiety. Some anxiety disorders are hypothesized to develop from failures in this local
inhibitory circuit. Distinct populations of these inhibitory neurons express patterns of calciumbinding proteins and neuropeptides that suggest differences in functionality within the lateral
amygdala. Furthermore, these patterns of expression are compared between male and female rats
to identify sex differences in the lateral amygdala. Previous studies have reported sex differences
in amygdala activation and connectivity, but very little is known about the sexual dimorphism of
calcium-binding protein and neuropeptide expression.
These cell-type markers can be identified through immunohistochemistry, in which a
target protein is tagged with a primary antibody, which is itself tagged and visualized with a
fluorescent secondary antibody. While previous studies have explored this question through
double-labeling, this study is unique in that it investigates the expression of these proteins
through serial multiplex labeling. The advantage to serial multiplex labeling is that a single
neuron can be labeled for ten or more cell-type markers, while previous studies have only been
able to examine two or three at a time. Characterization of these subpopulations lends to a
greater understanding of how the lateral amygdala functions within the fear and anxiety circuit
and how the rat model can be applied to human neurobiology.
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Introduction
The Amygdala
The amygdala is a brain region in the
cerebral hemispheres of vertebrates, specifically
the temporal lobe of primates and caudoventral
forebrain of rodents, which regulates emotions
(Pitkӓnen, 2000). Its dysfunction has been
implicated in several human neurological and
psychiatric disorders, such as anxiety, epilepsy,
schizophrenia, depression, and Alzheimer’s
disease (Mears & Pollard, 2016). It can be
subdivided into several nuclei (Figure 1),
including the basolateral nuclear complex (BNC),
which plays a significant role in processing
sensory input in the context of fear conditioning

Figure 1. Nuclei of the rat amygdala. Ldl, Lvl
and Lvm comprise lateral amygdala, BLp, BLa,
BLv, and BMp comprise basal amygdala, CL
and CM comprise central amygdala. Ldl =
dorsolateral lateral, Lvl = ventrolateral lateral,
Lvm = ventromedial lateral, BLp = posterior
basolateral, Bla = anterior basolateral, BLv =
ventral basolateral, BMp = posterior basomedial,
Copl = posterolateral cortical, CL = lateral
central, CM = medial central, IN = intercalated
nucleus, M = medial (Image from McDonald,
2020).

and anxiety (Herry et al., 2010; LeDoux, 2000; Pape & Paré, 2010; Tovote et al., 2015). The
BNC can be divided into lateral (LA), basolateral (BL), and basomedial (BM) nuclei, each with
distinct roles within the fear and anxiety circuit. Each of these regions can be further subdivided
along the ventro-dorsal and rostro-caudal axes (Paxinos & Watson, 1997).
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Pyramidal Neurons
The projecting neurons of the LA are classified as pyramidal, similar to other brain areas
such as the cortex. Their cell bodies measure about 10-35 microns across, with a single apical
dendrite extending 400 to 700 microns from the cell body and 4 to 6 basal dendrites extending 5
to 20 microns. Level of branching varies greatly between neurons. The axons originate from the
apical, basal, or lateral side of the cell body and project caudally (Hall, 1972; McDonald, 1982;
1984; Millhouse and DeOlmos, 1983). Pyramidal, or class I, neurons comprise about 85 percent
of all LA neurons (McDonald, 1992) and are the main projection neurons from the LA to the
prefrontal cortex and ventral striatum, utilizing excitatory neurotransmitters glutamate and
aspartate (Fuller et al., 1987; McDonald, 1996; Smith and Paré, 1994). LA pyramidal neurons
receive both inhibitory input at symmetric synapses via γ-aminobutyric acid (GABA) and
excitatory input at asymmetric synapses via glutamate (Hall, 1972; Carlsen and Heimer, 1988;
LeDoux et al., 1991; Stefanacci, et al., 1992; Smith and Paré, 1994; Brinley-Reed et al., 1995;
Paré et al., 1995; Farb and LeDoux, 1999; Smith et al., 2000; Muller et al., 2006).

Non-Pyramidal Neurons
While pyramidal neurons have relatively consistent properties across the literature, nonpyramidal neurons vary greatly in morphology (McDonald and Augustine 1993; Paré and Smith,
1993; Lang and Paré, 1998; Smith et al., 2000). These class II and III LA cells comprise the
population of interneurons, which provide most of the inhibitory input to pyramidal cells
(Carlsen, 1988; McDonald et al., 2002). About one-quarter of non-pyramidal LA neurons are
stellate cells. These have rounded cell bodies of about 10-15 microns in diameter, with 5 to 10

7
dendrites projecting in all directions and highly branched axons. Stellate cells typically are found
singly and surrounded by pyramidal neurons. Another group of non-pyramidal neurons are
known as cone cells, which have fusiform cell bodies about 20 to 25 microns wide and 30 to 35
microns long. These unusual cell bodies split into two or three branches before dividing into
dendrites. Several other shapes and forms of interneurons have been identified in the LA that
make this such a heterogenous group of cells (Millhouse and DeOlmos, 1983). There is some
disagreement in the literature on where to draw the line between class II and III cells, but they
are typically organized by size, with larger non-pyramidal cells comprising class II and smaller
in class III. Neurogliaform cells, characterized by extensive branching of their axons, fall into
class III (McDonald, 1992). The diversity of non-pyramidal interneurons is of particular interest
to this study.
Many studies differentiate LA interneurons neurons based on patterns in molecular
expression. This idea implies that neurons with different functions must have different
intracellular components to accomplish these functions. Research has frequently targeted the
expression of receptor proteins, neuropeptides, and calcium-binding proteins (McDonald and
Pearson, 1989; McDonald and Mascagni, 2001a; Kemppainen and Pitkӓnen, 2000).
Unfortunately, the specific functions of many of these molecules remain unknown, so the current
literature mainly catalogs presence, trends, and immunoreactivity between the molecules.

Receptor Proteins
Receptor proteins are a physiologically important type of molecule that can be helpful in
differentiating cell types. The presence or absence of a receptor can give insight into the cell’s
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function and also provide potential pharmacological targets. The main function of the amygdala
is fear memory consolidation, so many studies investigate the receptors associated with this
process. L-type voltage-gated calcium channels (VGCCs) are required for long-term potentiation
(LTP), a key process in learning. The expression of a VGCC on an LA neuron could suggest it
plays a role in LTP, which can be supported by behavioral tests. However, LTP also requires the
expression of N-methyl-D-aspartate receptors (NMDARs) for fear acquisition. Expression of
these two receptors can help identify potential subpopulations of neurons involved in these
learning processes (Bauer et al., 2002). Other important receptors involved in LTP and fear
memory formation include D2 dopamine receptors, CB1 cannabinoid receptors, group I
metabotropic glutamate receptor subtype mGluR5, and serotonergic 5-HT receptors (Stutzmann
and LeDoux, 1999; McDonald and Mascagni, 2001b; Rodrigues et al., 2002; Bissiere et al.,
2003). Expression of receptor proteins in the LA is not investigated in this thesis. However, these
listed are just a small sample of the receptor proteins expressed on LA cells and undoubtedly
play a significant role in the functional differences of these neurons.

Neuropeptides
Neuropeptides are proteins found consistently in neurons having a range of functions
including neurotransmission, modulation, and other signaling. Those found in highest
concentration in the LA include vasoactive intestinal polypeptide (VIP), cholecystokinin
octapeptide (CCK), somatostatin (SOM), and neuropeptide Y (NPY) (Roberts et al., 1982). Since
GABA is a known inhibitory neurotransmitter, it is frequently used in studies to determine
colocalization with these neuropeptides to identify trends and suggest possible associated
functions. One study found that GABA-positive (GABA+) non-pyramidal cells were
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immunoreactive for these neuropeptides in the following percentages: 14.3 percent SOM, 14.9
percent NPY, 17.4 percent VIP, and 7.9 percent CCK (McDonald and Pearson, 1989). This is
just one example of the many studies investigating the colocalization of neuropeptides with
GABA. Each GABAergic, neuropeptide-expressing cell can be considered as its own cell type
and investigated for immunoreactivity with other neuropeptides and calcium-binding proteins.

Calcium-Binding Proteins
Calcium-binding proteins are found in high prevalence throughout the brain, but beyond
binding to calcium, their exact function is not always clear. Since calcium is an important
signaling molecule in the brain, there is a lot of speculation about the function of calciumbinding proteins. Like neuropeptides, they are also found in LA non-pyramidal neurons and
exhibit immunoreactivity with GABA, notably parvalbumin (PV), calbindin-D28k (CalB), and
calretinin (CalR). GABA+ LA cells were immunoreactive for these calcium-binding proteins in
the following percentages: 41.2 percent CalB, 19 percent PV, and 20.5 percent CalR. A total of
57.8 percent of GABA+ neurons were immunoreactive for at least one calcium-binding protein
(McDonald and Mascagni, 2001a).
As stated in the Neuropeptides section, each calcium-binding protein can be used to
classify individual types of cells based on immunoreactivity with other molecules (Figure 2).
One study defined three major subpopulations of GABAergic neurons in the LA: SOM+ neurons
containing CalB and/or NPY, PV+ neurons containing CalB, and CalR+ neurons containing VIP
(McDonald and Mascagni, 2002). It is important to note that these are general trends and do not
describe every single GABAergic interneuron in the LA. CCK expression characterizes two
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major subpopulations of LA neurons:
type L neurons, with large cell bodies
and thick dendrites, and type S neurons,
with small cell bodies and thin dendrites.
Type L CCK+ neurons colocalized with
CalB, but not PV, CalR, or VIP. On the
other hand, type S CCK+ neurons
colocalized with CalR and VIP, but not
CalB or PV (Mascagni and McDonald,
2003).
This study examines the
expression of CalB, CalR, and PV.
Based on the work of McDonald, it was
hypothesized that two major classes of
LA interneuron would present. One type
Figure 2. Overlap and relative ratios of GABAergic
nonpyramidal neurons in rat basolateral and lateral
amygdala nuclei. CB = calbindin, CR = calretinin, PV =
parvalbumin, SOM = somatostatin, NPY = Neuropeptide Y,
CCK = cholecystokinin, VIP = vasoactive intestinal peptide.
(Image from McDonald, 2020).

would be CalB+, some of which also
express PV. The other type would be
CalR+. These two populations should
exhibit very low levels of overlap in

expression (McDonald, 2020). While guided by McDonald’s work, this thesis project is novel in
its methods.
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Sex Differences
Another important factor to consider in LA circuitry is the difference in expression
between males and females. In humans, biological men and women exhibit different prevalence
of psychiatric disorders, many of which involve the amygdala. For example, anxiety is diagnosed
in 40.4% of adult women as opposed to 26.4% in adult men (Kessler et al., 2005; Kessler et al.,
2012). Additionally, alcohol use disorder is twice as prevalent in men, and men tend to exhibit
more severe symptoms (Substance Abuse and Mental Health Services Administration, 2019;
Deshmukh et al., 2003; Erol & Karpyak, 2015). Some, but very few, projects have examined sex
differences in calcium-binding protein expression. A few notable findings include higher
expression of CalB+ interneurons in female guinea pigs and high colocalization of PV and
estrogen receptor beta in the LA (Równiak et al., 2015; Blurton-Jones & Tuszynski, 2002).
Blume et al. (2017) investigated LA differences between males and females, as well as
differences within females at different stages of the estrus cycle: proestrous, characterized by
high estradiol, and diestrous, characterized by low estradiol. The study examined many criteria,
including morphology, electrophysiology, and PV expression. Significantly less PV+ cells were
found in females than males, as well as less in proestrous than diestrous females. It is clear from
these limited studies that the LA is sexually dimorphic in expression of calcium-binding proteins
and further characterization is necessary (Blume et al., 2017). Through the methods described in
this paper, male, proestrous female, and diestrous female rat LA sections can be processed at a
high volume in a relatively short time to better identify these patterns and sex differences.
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Dual-Labeling vs. Serial Multiplex IHC

Figure 3. Example of dual-labeling immunohistochemistry procedure. In this example, the proteins of interest
are cholecystokinin (CCK) and calbindin (CalB), whose antigens are represented by a red circle and green
triangle, respectively. Primary antibodies bind directly to the antigens. Secondary antibodies then recognize and
bind to the primary antibodies. The secondary antibodies are visualized by their conjugated Alexa Fluor
markers.

McDonald identified these neuronal subpopulations through dual-labeling
immunohistochemistry (IHC). In this method, the researcher applies two primary antibodies for
two different protein targets to a single sample, usually 50 microns thick. For example, to
identify CCK and CalB expression on a single sample, one could apply mouse anti-CCK and
rabbit anti-CalB primary antibodies. The primary antibodies then must be visualized by
fluorescent secondary antibodies, in this case Alexa-546 goat anti-mouse for CCK and Alexa488 goat anti-rabbit for CalB (Figure 3). The Alexa-546 will mark CCK+ cells in a red channel,
and the Alexa-488 will mark CalB+ cells in a green channel. Therefore, any cell expressing both
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proteins will appear yellow when the two different color channels are overlapped (McDonald,
2021). While effective, this method has its limitations. For one, it is limited to identifying only
two or three protein markers at a time. This is because in order for each to fluoresce a different
color, its antibody must be from a different host species. In the previous example, CCK was a
mouse antibody and CalB was a rabbit antibody. If each of these antibodies were only
commercially available or proven to be effective in the same host species, it would be impossible
to differentiate the expression of the two. This is a very likely dilemma, as only certain
combinations of species to antibody are available, and the reliability of these antibodies to label
exactly what they intend varies greatly.
To address this problem, this study employs serial multiplex IHC. For the exact
procedure, refer to the Materials and Methods section, but the key difference is the thickness of
the sample. McDonald typically used 50 micron-thick sections, while this study uses 100
nanometer ultrathin sections. This allows for up to 500 times more experiments to be done on the
same region of tissue. The width of a typical neuronal cell body ranges from about 10 to 35
microns, so serial sections cut at 100 nanometers could theoretically allow for 100 or more
sections through a single neuron. Because of this flexibility, each sample can be labeled with a
different antibody without needing to avoid overlap of host species. For example, section 1 could
use rabbit anti-CalB, section 2 could use rabbit anti-CalR, section 3 could use rabbit anti-PV,
section 4 could use rabbit anti-VIP, section 5 could use rabbit anti-CCK, section 6 could use
rabbit anti-NPY, and this could continue all the way through a single neuron with dozens of
different antibodies. Alexa-488 goat anti-rabbit can then be used as the secondary antibody for
all 4 sections, since they will be imaged and compared independently. This also eliminates the
issue of different secondary antibodies exhibiting disparities in strength of fluorescent signal
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incongruent to the levels of expression. One challenge with IHC is that false positive signal is
very common and difficult to distinguish from real signal. By using the serial multiplex method,
one can label consecutive sections with the same antibody to verify that the same neurons are
labeled in both sections.

Materials and Methods
Animals and Tissue Preparation
An adult Sprague Dawley rat was perfused with 4% paraformaldehyde in 0.1M 1,4piperazinediethanesulfonic acid (PIPES) buffer with 2mM CaCl2 and 4mM MgCl2. The tissue
was microwave-embedded in 1:4 methyl-butyl methacrylate (MBA) resin. The MBA was
prepared by adding 20 grams of methyl methacrylate to 80 grams of n-butyl methacrylate. This
was mixed with dry nitrogen for 15 minutes. Next, 0.5 grams of benzoin methyl ether were
mixed in for another 15 minutes in dry nitrogen. The tissue was dehydrated in increasing
amounts of ethanol for 40 seconds at a time, at 37°C in a microwave. The dehydration solvent
began as 50% ethanol in water for the first 40 seconds, then 70% ethanol for the next 40 seconds,
90% ethanol for 40 seconds, and finally two rounds of 100% ethanol for 40 seconds each. With
the tissue fully dehydrated, resin infiltration began with a 1:1 solution of ethanol to MBA, which
was microwaved for 15 minutes at 45°C. Two rounds of infiltration with 100% MBA followed,
each for 15 minutes in the microwave at 45°C. Finally, polymerization took place in an
Automatic Freeze Substitution (AFS) machine at 4°C under ultraviolet light for 48 hours.
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Ultrathin Sectioning

Figure 4. A, Arrangement of 100nm ultrathin serial sections 1-32 on subbed coverslips 1-6. All were processed
for IHC as described in Methods. B, 500nm-thick sections taken immediately following sections 10, 20, and 30.
Stained for Toluidine Blue on a subbed slide. C, Stepwise depiction of ultramicrotomy (Image from Ziel, 2013).

Sections were cut using a DiATOME Histo diamond knife on a Leica EM UC7
Ultramicrotome and placed on subbed 24mm x 60mm coverslips. Coverslips were prepared by
dipping 5 times for 5 seconds each in gelatin-coating solution (0.5% gelatin, 0.05% chromium
potassium sulfate dodecahydrate in 45°C deionized water). 100 nanometer ultrathin serial
sections 1-32 were placed on slides 1-6 for IHC, according to Figure 4. After sections 10, 20,
and 30, 500 nanometer-thick sections were placed on a subbed slide, to be stained for Toluidine
Blue. Serial sections were warmed on a slide warmer at 60°C for 5 minutes. Toluidine Blue was
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applied for one minute while warmed at 60°C. Slides were stored in a desiccator to keep sections
dry.

Immunohistochemistry
The rinse solution (PBST) was 0.01M Phosphate-Buffered Saline, pH 7.4, with 0.1%
Tween-20. The blocking solution was PBST with 1% Bovine Serum Albumin (BSA). This was
used for the initial blocking step, as well as dilution of all primary and secondary antibodies. The
primary antibodies for PV, CalB, and CalR target the calcium-binding proteins as previously
described. The anti-GABA antibody identifies which cells are inhibitory (interneurons), as
opposed to glutamatergic projecting neurons. Anti-Myelin Basic Protein (MBP) labels
myelinated axons and is useful for delineating the boundaries of the LA. The negative control is
not labeled with a primary antibody but does receive Alexa 488 goat anti-rabbit secondary
antibody. This controls for any autofluorescence induced by the secondary in absence of
primary.
Two slightly differing conditions were used for this experiment. For Slides 1-4 and 6
(stained for MBP, PV, CalB, CalR, and negative control), the following procedure was followed:
Slides were immersed in 100% reagent grade acetone for 10 minutes to remove resin. The slides
were then treated for antigen retrieval, by placing in an Instant Pot Pressure Cooker with 0.1M
sodium citrate buffer, pH 6.0, for 10 minutes at “normal” pressure and “high” heat settings. The
sections were then rinsed with PBST twice for 2 minutes each. BSA/PBST blocking solution was
applied for 15 minutes. Immediately following blocking, primary antibodies (Table 1) were
applied for 60 minutes. During the primary step, the negative control slide remained immersed in
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BSA/PBST with no primary antibody. Sections were then rinsed with PBST twice for 2 minutes
each. Secondary antibody (Table 2) was applied for 15 minutes. Sections were rinsed with PBST
twice for 2 minutes each. The mounting medium, ProLong Gold Antifade Mountant with 4’6diamidino-2-phenylindole (DAPI), was applied to each coverslip and flipped upside down to
adhere to the glass slide. The procedure for slide 5 (GABA) had slight differences in the first
steps. No acetone or pressuring cooking was done on this slide. Instead, sections were rinsed
twice for 2 minutes each with PBST. Then, sections were immersed in 2% glutaraldehyde in
PBST for 5 minutes. Sections were rinsed with 10mM glycine in PBST, three times for 2
minutes each. From this point on, the GABA slide joined slides 1-4 and 6 in rinsing, blocking,
primary, secondary, and mounting steps. The only exception was that each subsequent rinse was
done with the glycine/PBST solution, instead of just PBST like the other five slides. All slides
were stored overnight in a dark refrigerator at 4°C.
Table 1. Primary antibodies and dilutions. All dilutions in BSA/PBST.
Antibody
Target
Myelin Basic
Protein
Parvalbumin
Calbindin
Calretinin
GABA

Host Species

Dilution

Brand

Catalog #

Lot #

Mouse

1:50

BioLegend

808401

B315597

Rabbit
Rabbit
Rabbit
Rabbit

1:1000
1:50
1:50
1:50

Abcam
SySy
SySy
Sigma

Ab11427
214003
214102
A2062

GR3407557-2
1-2
1-4
000011384712109121

Table 2. Secondary antibodies and dilutions. All dilutions in BSA/PBST.
2° Antibody
Alexa 488
Goat antiRabbit
Alexa 488
Goat antiMouse
Alexa 594
Goat antiRabbit

1°
Antibodies
Targeted
PV, CalB,
CalR,
negative
control

Dilution

Microscope
Channel

Brand

Catalog #

Lot #

1:200

GFP

Invitrogen

A32731

VL315532

MBP

1:200

GFP

Invitrogen

A11001

2318440

GABA

1:200

Texas Red

Invitrogen

A32740

WK333741
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Imaging and Cell Counting
All slides were imaged on an Andor Widefield microscope with Nikon Eclipse Ti at 10x,
20x, 40x, and 100x. All slides were imaged in a DAPI fluorescent channel, which visualizes the
nuclei of cells. Slides 1-4 and 6 were also imaged in a Green Fluorescent Protein (GFP) channel,
which visualizes the labeling of Alexa 488 secondary antibodies. Slides 5 was imaged in a Texas
Red channel, which visualizes the labeling of Alexa 594 antibodies.
Images were analyzed in ImageJ and aligned using an ImageJ plugin created by Ostroff
Lab member, Alison Chase. Once aligned, the MBP slide was used to determine the boundaries
of the BLA. Since MBP labels white matter, it shows a clear triangle-like shape that outlines the
BLA. From there, a line was drawn from the internal capsule at the middle of the central
amygdala, directly across BLA to the external capsule (Figure 5). This roughly divides the BLA
into lateral and basal nuclei, however as described in Introduction, the exact boundary of the two
nuclei is not well characterized in the literature. These boundaries could then be traced across all
sections to make consistent cell counts. This was all done in close sections in order to maintain
the same cells throughout the tissue. Since the same antibody was labeled on consecutive
sections, many sections were redundant. As a result, the sections of each antibody with clearest
labeling were used for cell counting. In this case, section 1 was used for MBP, section 4 for PV,
section 6 for CalB, section 7 for CalR, and section 10 for GABA.
Next, total cell counts were made in the 20x DAPI channel images to determine the total
number of cells contained within this slice of amygdala. Since DAPI labels all cells, this includes
projecting neurons and glial cells in addition to interneurons. The GABA slide was used as the
determinant of interneurons, since they are all GABAergic. CalB was the next cell type marker
to be counted, because according to McDonald, it should constitute the largest population of
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interneurons. PV was then counted, because it should exhibit high levels of colocalization with
CalB. Finally, CalR+ cells were counted, and these should overlap with neither CalB nor PV.
These counts were analyzed for colocalization with other calcium-binding proteins and
expression patterns were compared with expected percentages based on previous studies.

Results
According to the DAPI labeling, there were 230 total cells in BA and 298 in LA. The
Texas Red images showed that out of the 230 BA cells, 38 (16.52%) were GABA+ interneurons,
and of the 298 LA cells, 34 (11.41%) were GABA+ interneurons. The GFP images showed that
in the BA, there were 11 CalB+ cells out of the 38 interneurons (28.95%). In the LA, there were
6 CalB+ cells out of 34 interneurons (17.65%). The BA had 7 PV+ cells, which comprised
18.42% of interneurons and 63.64% of CalB+ cells. The LA had 3 PV+ cells, which were 8.82%
of interneurons. Only 2 of the 3 PV+ LA cells also expressed CalB, accounting for 33.33% of
LA CalB cells. All PV+ cells were also immunoreactive for CalB in BA. CalR was expressed in
4 BA cells, which was 10.53% of BA interneurons, and 4 LA cells, which was 11.76% of LA
interneuronns. None of the CalR+ cells expressed CalB or PV. See Table 3, Figure 5, and
Figure 6.
Table 3. Breakdown of calcium-binding protein expression in GABAergic interneurons.
Nucleus
Basal

Lateral

Calcium-Binding
Protein (CBP)
Calbindin
Parvalbumin
Calretinin
Calbindin
Parvalbumin
Calretinin

# of CBP+ cells

# of GABA+ cells

11
7
4

38

6
3
4

34

% of GABA+ cells
expressing CBP
28.95%
18.42%
10.53%
17.65%
8.82%
11.76%
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Figure 5. 10X images of MBP (section 1), GABA (section 10), CalB (section 6), PV (section 4), and CalR
(section 7) staining in BLA. MBP was used to identify the boundaries of the amygdala. The internal (green) and
external (blue) capsules mark the medial and lateral boundaries, respectively, of the basolateral amygdala. The
yellow line roughly divides the BLA into lateral and basal nuclei. Central amygdala is outlined in red. GABA
images were taken in Texas Red fluorescent channel, MBP/CalB/PV/CalR in GFP. Yellow circles indicate cells
that are only CalB+, blue circles are only PV+, green circles indicate CalB and PV colocalization, orange circles
indicate CalR+ only cells.
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Figure 6. 100x images of CalB and PV staining showing colocalization of CalB and PV. Each unique
color of arrow indicates the same cell between sections. The cells indicated by red, yellow, light
blue, purple, and light green arrows all express both CalB and PV. However, the cell labeled by the
white arrow only expresses CalB (Imaging credit to Rebecca Tripp).

Discussion
The patterns and cell populations displayed in these results follow some of the key trends
identified by McDonald: high level of colocalization between CalB and PV, a small subset of
PV+/CalB- cells, and no colocalization of CalR+ and CalB+ or PV+ cells. Some differences
were observed in the percentages of each category. McDonald observed that of all BLA
GABAergic cells, 41.2% were CalB+, 20.5% CalR+, and 19% PV+. While the numbers in this
study were significantly lower, the trends were similar. Figure 7 is a Venn diagram of the
relative number of cells expressing calcium-binding proteins based on McDonald’s style that
reflects the data in this study. When compared to Figure 2, it is clear the CalB, CalR, and PV
portions of the Venn diagram are very similar. The most prevalent group in each nucleus were
CalB+ cells (28.95% in BA, 17.65% in LA), with CalR (10.5% in BA, 11.8% in LA) and PV
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(18.4% in BA, 8.8% in LA) close in expression. One explanation for this discrepancy is that
McDonald’s data comes from averages of a career’s worth of data collection throughout the
amygdala, while this is obtained from a single experiment at one specific point along the rostrocaudal axis. Given that the expected trends in expression are present, it is likely that analyzing an
equivalent amount of data would yield similar results.

Figure 7. Populations of calcium-binding proteins in basal and lateral amygdala determined by serial multiplex
IHC. Each are depicted in their relative ratios. A, In BA, there were 3 clear populations identified: CalB+/PV-,
CalB/PV+, and CalR+. B, In LA, these 3 populations were also present, but there was an additional group of
PV+/CalB-.

While the data are important, the real success of this study is its potential to transform the
field of immunohistochemistry and drastically increase the level of work output and efficiency.
In a single rat, thousands of ultrathin sections can be stained for a nearly unlimited number of
antibodies. Previous studies would dual-label two antibodies on 50 microns of tissue at a time in
order to combine data and form a complete picture of the different interneuron populations. This
shows that individual neurons can be followed across 100 nanometer sections to identify the
contents of each specific neuron. This has clear advantages in yielding much more data from a
given amount of tissue, as well as utilization of many different conditions.
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These advantages do not come without challenges, which took significant time to work
around. Since serial multiplexing is a novel method, protocols underwent lengthy trial-and-error
and fine-tuning. For example, the proper dilutions of each antibody had to be perfected. There
are dozens of examples of IHC on thick sections, but ultrathin tissue has less available antigens
and requires greater concentrations of antibody to bind. This also led to experimenting with resin
removal and antigen retrieval to increase binding sites. While acetone and pressure cooking in
acid was determined to yield the best labeling, it was not the case for every antibody. For
example, it became clear that GABA antibodies actually labeled better without acetone or
pressure cooking, and instead prefer glutaraldehyde and glycine treatment. Incubation times of
primary and secondary antibodies were significantly reduced from IHC on thick sections as to
reduce extraneous labeling. While this took time to perfect, it resulted in a much more efficient
protocol that allows IHC to be completed in a few hours as opposed to multiple days.
Another challenge of ultrathin IHC is collection of the ultrathin sections themselves.
Mastering the ultramicrotome is a process that takes several months and requires significant
patience. It involves working with a block of tissue only a few millimeters wide, ultrathin
sections that are nearly invisible to the naked eye, and extra care not to damage the diamond
knife. Additionally, mounting sections on traditional glass slides was determined to be less than
ideal for imaging ultrathin sections. Since the tissue is so thin, the sections must be mounted
directly on coverslips, so the imaging does not take place through the mounting medium in
addition to the glass coverslip.
Finally, it is critical to have confirmation of the labeling that is observed. Cell counting
was always done with images of 20x magnification or greater since it is too difficult to
differentiate signal from background at 10x. Even at 20x, higher magnification images of 40x or
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100x were almost always used to confirm the labeling. Figure 8 shows how the image
significantly increases in clarity from 10x to 20x to 40x to 100x. However, even at 100x,
additional levels of verification are required. The 100x GFP image appears to show 5 clearly
labeled cell bodies. When overlayed with the same field in the DAPI channel, it becomes
ambiguous with two apparently labeled cells missing nuclei. They label an area of the tissue
where the nucleus is absent either because this slice of tissue does not contain it, or there is no
cell in that location at all. As a result, a nearby serial section with the same primary antibody
must be used for comparison. In the example in Figure 8, the following serial section had been
labeled for the same antibody and allowed for verification of the cell labeling. Because of this
common occurrence in IHC of imperfect labeling, it requires experience and multiple levels of
verification before drawing definite conclusions.

Figure 8. 10x, 20x, 40x, & 100x images of PV staining. This figure demonstrates the need for multiple levels of
verification in determining correct immunolabeling. In the 100x GFP image, there appear to be 5 PV+ cells,
however the DAPI channel shows there are no actual nuclei located at those apparent cells circled in white. As a
result, the next immediate serial section (also labeled for PV) is used to determine if the labeling pattern is
consistent. In this case, the same cells are immunolabeled, indicating a faithful labeling pattern (Imaging credit
to Rebecca Tripp for 40x & 100x images).
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Future Directions
While there are certainly challenges involved in serial multiplex IHC, there are clear
benefits to the method that open the door to new possibilities. By employing these methods, the
limited study done in this thesis can be expanded for a multitude of cell-type markers. This
includes the neuropeptides that have shown to colocalize with calcium-binding proteins. For
example, SOM, NPY, and CCK with CalB, and VIP and CCK with CalR. What others have
achieved across several years of work can be replicated and expanded in less than a week
through serial multiplex IHC.
Another important application of this method would be to compare sex differences in the
BLA. Very few studies have attempted to characterize the interneuronal subpopulations in
females as compared to males. This could also incorporate additional factors, such as estrous
cycle stage or behavioral conditions.
There are nearly unlimited neuropeptides and receptors that would be interesting and
useful to analyze on a large scale, but the following are of particular relevance to amygdala
circuitry, learning, and psychiatric/neurological disorders: calcium/calmodulin-dependent protein
kinase II (CaMKII), a protein involved in many functions such as plasticity, synaptic activity,
gene expression, and signaling cascades (Shioda and Fukunaga, 2018); Forkhead box protein P2
(FOXP2), an important transcription factor involved in brain activity (Den Hoed et al., 2021); cfos, the protein product of a proto-oncogene that marks neuronal activity (Bullitt, 1990);
vesicular glutamate transporters (VGLUT1 and VGLUT2) to identify excitatory synapses and
their relation to the interneuron populations (Herzog et al., 2006); vesicular GABA transporter
(VGAT) to identify GABAergic synapses in addition to the previously identified GABA+ cell
bodies (Wang et al., 2009); serotonin transporter (SERT), a marker of the neurotransmitter
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serotonin, which has been linked to a variety of neurological and psychiatric diseases (Kish et al.,
2005); norepinephrine transporter (NET), a marker of the neurotransmitter norepinephrine,
which mediates behaviors such as mood and depression (Bönisch and Brüss, 2006); neurokinin-1
receptor (NK-1R), which plays a role in stress response and pain (Duric and McCarson, 2005);
cannabinoid 1 receptor (CB1R), a potential factor in schizophrenia (Eggan et al., 2008);
calcitonin gene-related peptide (CGRP), which plays a role in migraines (Warfvinge and
Edvinsson, 2017); estrogen receptors alpha and beta (ERα and ERβ), indicators of the effect of
estrogen on the brain (Pérez et al., 2003); androgen receptor, which is suggested to play a
significant role in synaptic plasticity (Hajszan et al., 2008); and dopamine receptors 1 and 2
(D1R and D2R) and dopamine transporter (DAT), which are highly linked to addictive behaviors
and the reward pathway in the brain (Drago et al., 1998). Many if not all of these have been
proposed or proven to play important roles in a variety of psychiatric and neurological diseases.
Since the amygdala is implicated in many of these diseases as well, it would be a fascinating
study to identify the relationship between all of these and how they are expressed in the different
interneuron populations. The high-volume capacity of serial multiplex IHC allows for in-depth
studies of significant neurobiological and psychiatric relevance to be possible.
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